• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2021年中国北京非新冠病毒感染人群血清抗SARS-CoV-2 IgM/IgG抗体血清流行率的波动趋势及其与外周血白细胞参数的相关性:一项真实世界研究

The Fluctuation Trend of Serum Anti-SARS-CoV-2 IgM/IgG Antibodies Seroprevalence in the Non-COVID-19 Infected Population and Correlation with Peripheral Blood Leukocyte Parameters in Beijing, China, 2021: A Real-World Study.

作者信息

Wang Pan, Yang Nan, Xue Yuting, Zhou Jiansuo, Wu Yonghua, Wang Tiancheng, Cui Liyuan

机构信息

Department of Laboratory Medicine, Peking University Third Hospital, Beijing 100191, China.

Core Unit of National Clinical Research Center for Laboratory Medicine, Beijing 100191, China.

出版信息

Vaccines (Basel). 2022 Apr 7;10(4):571. doi: 10.3390/vaccines10040571.

DOI:10.3390/vaccines10040571
PMID:35455320
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9032992/
Abstract

Since 2019, the coronavirus disease 2019 (COVID-19) global pandemic has caused more than 300 million cases of disease and 5 million deaths. Vaccination has been widely accepted as the most effective measure for the prevention and control of this disease. However, there is little understanding about serum anti-SARS-CoV-2 IgM/IgG levels after inactivated vaccination as well as the relationship with peripheral blood leukocytes in the non-COVID-19 infected population. A total of 16,335 male and 22,302 female participants were recruited in this study, which was conducted in the Peking University Third Hospital located in Beijing (China). The level and seroprevalence of serum anti-SARS-CoV-2 receptor-binding domain (RBD) IgM/IgG and the association with peripheral blood leukocytes classification were investigated. With an increase in the number and percentage of full immunization of COVID-19 vaccinations in Beijing, serum anti-SARS-CoV-2 IgG antibodies levels and seroprevalence were significantly elevated (p < 0.01). The serum anti-SARS-CoV-2 IgG antibodies of 60 years and older persons were significantly lower than that of individuals that are 18~60 years old (p < 0.01), and there was a positive relationship between serum anti-SARS-CoV-2 IgG antibodies levels and peripheral blood lymphocyte count. The investigation of serum anti-SARS-CoV-2 IgM/IgG antibodies and the peripheral hematological index may prompt and help understand the adaptive immune response of vaccination.

摘要

自2019年以来,新型冠状病毒肺炎(COVID-19)全球大流行已导致超过3亿例病例和500万人死亡。疫苗接种已被广泛认为是预防和控制该疾病的最有效措施。然而,对于非COVID-19感染人群中灭活疫苗接种后的血清抗SARS-CoV-2 IgM/IgG水平以及与外周血白细胞的关系了解甚少。本研究共招募了16335名男性和22302名女性参与者,研究在北京(中国)的北京大学第三医院进行。研究了血清抗SARS-CoV-2受体结合域(RBD)IgM/IgG的水平和血清阳性率以及与外周血白细胞分类的关联。随着北京COVID-19疫苗全程接种数量和百分比的增加,血清抗SARS-CoV-2 IgG抗体水平和血清阳性率显著升高(p<0.01)。60岁及以上人群的血清抗SARS-CoV-2 IgG抗体显著低于18~60岁的个体(p<0.01),血清抗SARS-CoV-2 IgG抗体水平与外周血淋巴细胞计数呈正相关。对血清抗SARS-CoV-2 IgM/IgG抗体和外周血液学指标的调查可能有助于了解疫苗接种后的适应性免疫反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1905/9032992/e1b74b78dd41/vaccines-10-00571-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1905/9032992/5fe46870aafd/vaccines-10-00571-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1905/9032992/943fc44cd0f2/vaccines-10-00571-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1905/9032992/43ceadf2a44d/vaccines-10-00571-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1905/9032992/3153ed25fac4/vaccines-10-00571-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1905/9032992/e1b74b78dd41/vaccines-10-00571-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1905/9032992/5fe46870aafd/vaccines-10-00571-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1905/9032992/943fc44cd0f2/vaccines-10-00571-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1905/9032992/43ceadf2a44d/vaccines-10-00571-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1905/9032992/3153ed25fac4/vaccines-10-00571-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1905/9032992/e1b74b78dd41/vaccines-10-00571-g005.jpg

相似文献

1
The Fluctuation Trend of Serum Anti-SARS-CoV-2 IgM/IgG Antibodies Seroprevalence in the Non-COVID-19 Infected Population and Correlation with Peripheral Blood Leukocyte Parameters in Beijing, China, 2021: A Real-World Study.2021年中国北京非新冠病毒感染人群血清抗SARS-CoV-2 IgM/IgG抗体血清流行率的波动趋势及其与外周血白细胞参数的相关性:一项真实世界研究
Vaccines (Basel). 2022 Apr 7;10(4):571. doi: 10.3390/vaccines10040571.
2
Seroprevalence of SARS-CoV-2 infections among children visiting a hospital.到医院就诊儿童中新冠病毒感染的血清流行率。
Pediatr Investig. 2020 Dec 28;4(4):236-241. doi: 10.1002/ped4.12231. eCollection 2020 Dec.
3
Are SARS-CoV-2 Antibodies Detectable in Human Milk After Vaccination Against COVID-19?接种 COVID-19 疫苗后,人乳中能否检测到 SARS-CoV-2 抗体?
J Pediatric Infect Dis Soc. 2022 Apr 30;11(4):126. doi: 10.1093/jpids/piac024.
4
Human IgM and IgG Responses to an Inactivated SARS-CoV-2 Vaccine.人类针对灭活的 SARS-CoV-2 疫苗的 IgM 和 IgG 反应。
Curr Med Sci. 2021 Dec;41(6):1081-1086. doi: 10.1007/s11596-021-2461-8. Epub 2021 Nov 6.
5
Long-Term Kinetics of SARS-CoV-2 Antibodies and Impact of Inactivated Vaccine on SARS-CoV-2 Antibodies Based on a COVID-19 Patients Cohort.基于 COVID-19 患者队列的 SARS-CoV-2 抗体的长期动力学和灭活疫苗对 SARS-CoV-2 抗体的影响。
Front Immunol. 2022 Jan 27;13:829665. doi: 10.3389/fimmu.2022.829665. eCollection 2022.
6
Real-world serological responses to extended-interval and heterologous COVID-19 mRNA vaccination in frail, older people (UNCoVER): an interim report from a prospective observational cohort study.真实世界中衰弱老年人接受延长间隔和异源 COVID-19 mRNA 疫苗接种后的血清学反应(UNCoVER):一项前瞻性观察队列研究的中期报告。
Lancet Healthy Longev. 2022 Mar;3(3):e166-e175. doi: 10.1016/S2666-7568(22)00012-5. Epub 2022 Feb 23.
7
Longitudinal Profiling of Antibody Response in Patients With COVID-19 in a Tertiary Care Hospital in Beijing, China.中国北京一家三级甲等医院中新冠病毒肺炎患者抗体反应的纵向分析
Front Immunol. 2021 Mar 15;12:614436. doi: 10.3389/fimmu.2021.614436. eCollection 2021.
8
Unexpected Detection of Anti-SARS-CoV-2 Antibodies Before the Declaration of the COVID-19 Pandemic.在2019冠状病毒病大流行宣布之前意外检测到抗SARS-CoV-2抗体。
Front Med (Lausanne). 2022 Jul 11;9:923715. doi: 10.3389/fmed.2022.923715. eCollection 2022.
9
Evaluation of the correlation between the access SARS-CoV-2 IgM and IgG II antibody tests with the SARS-CoV-2 surrogate virus neutralization test.评估 SARS-CoV-2 IgM 和 IgG II 抗体检测与 SARS-CoV-2 替代病毒中和试验之间的相关性。
J Med Virol. 2022 Jan;94(1):335-341. doi: 10.1002/jmv.27338. Epub 2021 Oct 5.
10
Antibody Responses to BNT162b2 Vaccination in Japan: Monitoring Vaccine Efficacy by Measuring IgG Antibodies against the Receptor-Binding Domain of SARS-CoV-2.日本对 BNT162b2 疫苗的抗体反应:通过测量针对 SARS-CoV-2 受体结合域的 IgG 抗体来监测疫苗效力。
Microbiol Spectr. 2022 Feb 23;10(1):e0118121. doi: 10.1128/spectrum.01181-21. Epub 2022 Jan 19.

本文引用的文献

1
Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.在真实环境中评估灭活 COVID-19 疫苗诱导的 SARS-CoV-2 特异性体液和细胞免疫应答的特征。
Front Immunol. 2021 Dec 22;12:802858. doi: 10.3389/fimmu.2021.802858. eCollection 2021.
2
Response and Duration of Serum Anti-SARS-CoV-2 Antibodies After Inactivated Vaccination Within 160 Days.接种灭活疫苗后 160 天内血清抗 SARS-CoV-2 抗体的反应和持续时间。
Front Immunol. 2021 Dec 23;12:786554. doi: 10.3389/fimmu.2021.786554. eCollection 2021.
3
Differential Antibody Response to Inactivated COVID-19 Vaccines in Healthy Subjects.
健康受试者中对灭活 COVID-19 疫苗的抗体反应差异。
Front Cell Infect Microbiol. 2021 Dec 16;11:791660. doi: 10.3389/fcimb.2021.791660. eCollection 2021.
4
Performance verification of five commercial RT-qPCR diagnostic kits for SARS-CoV-2.五种用于 SARS-CoV-2 的商业 RT-qPCR 诊断试剂盒的性能验证。
Clin Chim Acta. 2022 Jan 15;525:46-53. doi: 10.1016/j.cca.2021.12.004. Epub 2021 Dec 10.
5
Long-term decay of anti-RBD IgG titers after BNT162b2 vaccination is not mirrored by loss of neutralizing bioactivity against SARS-CoV-2.BNT162b2 疫苗接种后抗 RBD IgG 滴度的长期衰减与对 SARS-CoV-2 的中和生物活性丧失并不一致。
Clin Chim Acta. 2022 Jan 1;524:11-17. doi: 10.1016/j.cca.2021.11.023. Epub 2021 Nov 27.
6
Hematological changes associated with COVID-19 infection.与 COVID-19 感染相关的血液学变化。
J Clin Lab Anal. 2022 Jan;36(1):e24064. doi: 10.1002/jcla.24064. Epub 2021 Nov 16.
7
Human IgM and IgG Responses to an Inactivated SARS-CoV-2 Vaccine.人类针对灭活的 SARS-CoV-2 疫苗的 IgM 和 IgG 反应。
Curr Med Sci. 2021 Dec;41(6):1081-1086. doi: 10.1007/s11596-021-2461-8. Epub 2021 Nov 6.
8
COVID-19 vaccination program in the mainland of China: a subnational descriptive analysis on target population size and current progress.中国内地的新冠病毒疫苗接种计划:关于目标人群规模和当前进展的省级以下描述性分析
Infect Dis Poverty. 2021 Oct 15;10(1):124. doi: 10.1186/s40249-021-00909-1.
9
Comparison of five commercial anti-SARS-CoV-2 total antibodies and IgG immunoassays after vaccination with BNT162b2 mRNA.接种BNT162b2 mRNA疫苗后五种商用抗SARS-CoV-2总抗体和IgG免疫测定法的比较。
J Med Biochem. 2021 Sep 3;40(4):335-340. doi: 10.5937/jomb0-31475.
10
Quantitative serological evaluation as a valuable tool in the COVID-19 vaccination campaign.定量血清学评估是 COVID-19 疫苗接种运动中的一项有价值的工具。
Clin Chem Lab Med. 2021 Oct 7;59(12):2019-2026. doi: 10.1515/cclm-2021-0364. Print 2021 Nov 25.